Imunon Inc (NAS:IMNN)

$ 0.7711 -0.0534 (-6.44%) Market Cap: 11.11 Mil Enterprise Value: 7.19 Mil PE Ratio: 0 PB Ratio: 1.94 GF Score: 38/100

Q3 2024 Imunon Inc Earnings Call Transcript
6 days ago

$0.8215 (-12.34%)

Earnings
Q2 2024 Imunon Inc Earnings Call Transcript
Aug 14, 2024

$0.9564 (-11.44%)

Earnings
Q1 2024 Imunon Inc Earnings Call Transcript
May 13, 2024

$1.48 (+7.25%)

Earnings
Q4 2023 Imunon Inc Earnings Call Transcript
Mar 28, 2024

$1.64 (+17.14%)

Earnings
Q3 2023 Imunon Inc Earnings Call Transcript
Nov 14, 2023

$0.95 (-3.57%)

Earnings
Imunon Inc R&D Day Transcript
Sep 14, 2023
Q2 2023 Imunon Inc Earnings Call Transcript
Aug 10, 2023

$1.21 (-3.20%)

Earnings
Q1 2023 Imunon Inc Earnings Call Transcript
May 11, 2023

$1.28 (-5.19%)

Earnings
Q4 2022 Imunon Inc Earnings Call Transcript
Mar 30, 2023

$1.27 (-2.31%)

Earnings
Q3 2022 Imunon Inc Earnings Call Transcript
Nov 14, 2022

$1.47 (-4.10%)

Earnings
Q2 2022 Celsion Corp Earnings Call Transcript
Aug 15, 2022

$2.54 (-1.55%)

Earnings
Q1 2022 Celsion Corp Earnings Call Transcript
May 16, 2022

$2.56 (+0.39%)

Earnings
Q4 2021 Celsion Corp Earnings Call Transcript
Mar 31, 2022

$5.06 (-4.53%)

Earnings
Q3 2021 Celsion Corp Earnings Call Transcript
Nov 15, 2021

$12.74 (+1.36%)

Earnings
Celsion Corp at Chardan Genetic Medicines Conference (Virtual) Transcript
Oct 05, 2021
Q2 2021 Celsion Corp Earnings Call Transcript
Aug 12, 2021

$15.75 (-1.87%)

Earnings
Q1 2021 Celsion Corp Earnings Call Transcript
May 14, 2021

$15.6 (+5.05%)

Earnings
Q4 2020 Celsion Corp Earnings Call Transcript
Mar 19, 2021

$33.6 (-1.32%)

Earnings
Q3 2020 Celsion Corp Earnings Call Transcript
Nov 16, 2020

$7.95 (-1.49%)

Earnings
Q2 2020 Celsion Corp Earnings Call Transcript
Aug 14, 2020

$16.35

Earnings
Celsion Corporation - Special Call Transcript
Jul 15, 2020
Celsion Corp Annual Shareholders Meeting Transcript
Jun 15, 2020
Q1 2020 Celsion Corp Earnings Call Transcript
May 15, 2020

$20.1 (-1.47%)

Earnings
Q4 2019 Celsion Corp Earnings Call Transcript
Mar 26, 2020

$13.5 (-7.01%)

Earnings
Q3 2019 Celsion Corp Earnings Call Transcript
Nov 15, 2019

$18.45 (-11.51%)

Earnings
Q2 2019 Celsion Corp Earnings Call Transcript
Aug 15, 2019

$25.5 (+0.59%)

Earnings
Q1 2019 Celsion Corp Earnings Call Transcript
May 15, 2019

$34.05 (+6.07%)

Earnings
Q4 2018 Celsion Corp Earnings Call Transcript
Mar 29, 2019

$29.4 (-2.32%)

Earnings

Q4 2023 Imunon Inc Earnings Call Transcript

Mar 28, 2024 / 02:00PM GMT

Release Date Price: $1.64 (+17.14%)

Transcript 10-K8-K

Operator

Good morning my day. My name is Dave, and I will be your operator today. At this time, I would like to welcome you to ImmunoGen 2023 financial results conference call. (Operator Instructions) I would now like to turn the call over to Kim Golodetz. Please go ahead.

Kim Golodetz;Heilshorn;Associates

Lippert;Inc. - IR

/& -

Thank you, and good morning, everyone. This is Kim Golodetz with LHA. Welcome to ImmunoGen's 2023 financial results and business update conference call. During today's call, management will be making forward-looking statements regarding immunome expectations and projections about future events. In general, forward-looking statements can be identified by words such as expect, anticipates, believes or other similar expressions.

These statements are based on current expectations and are subject to a number of risks and uncertainties, including those set forth in the Company's periodic filings with the Securities and Exchange Commission. No forward-looking statements can be guaranteed, and actual

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.